https://orcid.org/0000-0002-5616-1650
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tushar Yadav, Swatantra Kumar, Gourav Mishra & Shailendra K. Saxena. (2023) Tracking the COVID-19 vaccines: The global landscape. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Articles from other publishers (13)
Dima A. Sabbah, Rima Hajjo & Suhair Sunoqrot. (2023) A Critical Assessment of COVID-19 Genomic Vaccines. Current Topics in Medicinal Chemistry 23:27, pages 2552-2589.
Crossref
Crossref
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi V. Vasilev, Luchesar Tomov & Tsvetelina Velikova. (2023) The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice. Vaccines 11:7, pages 1181.
Crossref
Crossref
R. Solanki, A. Shankar, U. Modi & S. Patel. (2023) New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention. Materials Today Chemistry 29, pages 101478.
Crossref
Crossref
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki & Vasso Apostolopoulos. (2022) The Vaccine World of COVID-19: India’s Contribution. Vaccines 10:11, pages 1943.
Crossref
Crossref
Monika Kumari, Ruei-Min Lu, Mu-Chun Li, Jhih-Liang Huang, Fu-Fei Hsu, Shih-Han Ko, Feng-Yi Ke, Shih-Chieh Su, Kang-Hao Liang, Joyce Pei-Yi Yuan, Hsiao-Ling Chiang, Cheng-Pu Sun, I.-Jung Lee, Wen-Shan Li, Hsing-Pang Hsieh, Mi-Hua Tao & Han-Chung Wu. (2022) A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. Journal of Biomedical Science 29:1.
Crossref
Crossref
V. V. Oberemok, O. A. Andreeva, K. V. Laikova, I. A. Novikov & A. V. Kubyshkin. (2022) Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond. Inflammation Research 71:7-8, pages 729-739.
Crossref
Crossref
Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, Mohammad Sharaf, Alexis J. Lannigan, Ian M. Sullivan, Alecsander P. da Silva, Leland O. Barrett, Scott McGoldrick, Yuvraj Lnu, Shannon E. Lynch, Jared M. Boisclair, Dakarai D. Barnard-Pratt & Steven Zanganeh. (2022) Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines. Antibodies 11:2, pages 35.
Crossref
Crossref
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, Maria Elsa Gambuzza, Claudio Pulvirenti, Annalisa Cozza, Andrea Corsonello, Filippo Luciani & Giovanni Rezza. (2022) COVID-19 Vaccines: Current and Future Perspectives. Vaccines 10:4, pages 608.
Crossref
Crossref
S.P. Papadakos, N. Mazonakis, M. Papadakis, C. Tsioutis & N. Spernovasilis. (2022) Pill versus vaccine for COVID-19: Is there a genuine dilemma?. Ethics, Medicine and Public Health 21, pages 100741.
Crossref
Crossref
Md. Aminul Islam, Md. Atiqul Haque, Md. Arifur Rahman, Foysal Hossen, Mahin Reza, Abanti Barua, Abdullah Al Marzan, Tuhin Das, Sumit Kumar Baral, Cheng He, Firoz Ahmed, Prosun Bhattacharya & Md. Jakariya. (2022) A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection. Frontiers in Immunology 13.
Crossref
Crossref
Giau Van Vo, Eva Bagyinszky & Seong Soo A. An. (2022) COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development. Microorganisms 10:3, pages 598.
Crossref
Crossref
Zhaohui Su, Ali Cheshmehzangi, Dean McDonnell, Claudimar Pereira da Veiga & Yu-Tao Xiang. (2022) Mind the “Vaccine Fatigue”. Frontiers in Immunology 13.
Crossref
Crossref
Iradhad Taqwa Sihidi, Achmad Apriyanto Romadhan, Dedik Fitrah & Mariano Mariano. (2022) Vaksin dan Sentimen Publik: Sebuah Analisis. Journal of Political Issues 3:2, pages 107-114.
Crossref
Crossref